Health food
-
DATABASE (331)
-
ARTICLES (378)
Apostolos Apostolakis is a serial entrepreneur turned investor. He has a Civil Engineering degree from NTUA and an MBA from Columbia Business School. His entrepreneurial career started after working two years as a consultant for the Boston Consulting Group until 2004. He became a co-founder and board member of various companies including VentureFriends, InstaShop, Douleutaras.gr, e-food.gr, Doctoranytime.gr and Blueground (formerly Openfund and Taxibeat). In 2010, he started investing in other startups, focusing on e-marketplaces and SaaS.
Apostolos Apostolakis is a serial entrepreneur turned investor. He has a Civil Engineering degree from NTUA and an MBA from Columbia Business School. His entrepreneurial career started after working two years as a consultant for the Boston Consulting Group until 2004. He became a co-founder and board member of various companies including VentureFriends, InstaShop, Douleutaras.gr, e-food.gr, Doctoranytime.gr and Blueground (formerly Openfund and Taxibeat). In 2010, he started investing in other startups, focusing on e-marketplaces and SaaS.
Horizons Ventures is a Hong Kong-based venture capital firm that manages the personal investments of Li Ka-shing, one of Hong Kong’s richest businessmen. Horizons’ investments cover a wide range of tech, media, and telecommunications companies. Standouts include artificial intelligence company DeepMind (acquired by Google in 2014), plant-based meat replacement makers Impossible Foods, and video conferencing software Zoom. It has also backed consumer-facing businesses like Atomo Coffee in Australia, Kopi Kenangan in Indonesia, and US-based distilled spirits company Endless West.
Horizons Ventures is a Hong Kong-based venture capital firm that manages the personal investments of Li Ka-shing, one of Hong Kong’s richest businessmen. Horizons’ investments cover a wide range of tech, media, and telecommunications companies. Standouts include artificial intelligence company DeepMind (acquired by Google in 2014), plant-based meat replacement makers Impossible Foods, and video conferencing software Zoom. It has also backed consumer-facing businesses like Atomo Coffee in Australia, Kopi Kenangan in Indonesia, and US-based distilled spirits company Endless West.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Formerly known as Google Ventures, GV is the investment arm of Alphabet Inc. Although Alphabet is its sole limited partner, the VC operates independently from Google. It invests in seed, venture and growth-stage funding rounds with more than 300 companies in its portfolio worth over $5bn. Headquartered in California’s Mountain View, GV has offices in San Francisco, Boston, New York and London. The VC has been actively involved in Silicon Valley’s investment rounds for prominent startups like Uber, Slack, Ripple, Impossible Foods, Lime and Medium.
Formerly known as Google Ventures, GV is the investment arm of Alphabet Inc. Although Alphabet is its sole limited partner, the VC operates independently from Google. It invests in seed, venture and growth-stage funding rounds with more than 300 companies in its portfolio worth over $5bn. Headquartered in California’s Mountain View, GV has offices in San Francisco, Boston, New York and London. The VC has been actively involved in Silicon Valley’s investment rounds for prominent startups like Uber, Slack, Ripple, Impossible Foods, Lime and Medium.
Founded in 2018, Oslo-based Katapult Ocean is the first investor focused entirely on oceantech and related startups. The VC also operates a three-month accelerator and has invested in 32 startups from 17 countries worldwide.The VC typically invests at the seed or pre-seed level but in July 2020 it completed its first Series A round of $8.5m investment in Chilean social enterprise Betterfly. Other recent investments include the pre-seed rounds of US foodtech GreenCover and Dutch offshore solar tech SolarDuck.
Founded in 2018, Oslo-based Katapult Ocean is the first investor focused entirely on oceantech and related startups. The VC also operates a three-month accelerator and has invested in 32 startups from 17 countries worldwide.The VC typically invests at the seed or pre-seed level but in July 2020 it completed its first Series A round of $8.5m investment in Chilean social enterprise Betterfly. Other recent investments include the pre-seed rounds of US foodtech GreenCover and Dutch offshore solar tech SolarDuck.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Taavet Hinrikus is the Estonian-born co-founder and CEO of money transfer platform and unicorn TransferWise (now called Wise). He was formerly Skype’s Director of Strategy and is a prolific angel investor across sectors and technologies, with investments in around 30 startups to date. His most recent investments include in the April 2021 $11m Series A round of automatic contract negotiator PACTUM and in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
Get fit and healthy with these Indonesian wellness startups
The wellness lifestyle trend continues to grow in popularity in Indonesia, and startups want a piece of the action
Healthy eating: The Southeast Asian startups making it a breeze
From meal plans to novel ingredients, agriculture and foodtech startups in the region are developing new ways to improve nutrition without sacrificing taste
Gorry Holdings: Promoting staff wellness in Indonesia
The healthtech startup wants companies to understand how healthy employees can translate into good business
Animal AgTech Innovation Summit 2021: Experts discuss post-pandemic priorities
The pandemic not only put digital tech in everyone’s hands, it also forced thinking about collecting meaningful data and moving it on-demand to both producers and decision makers
Future Food Asia 2021: Agrifood tech at an inflection point
Agrifood tech startups urged to harness consumer, investor and government feedback to create plentiful, nutritious food through sustainable means, but exercise caution when considering IPOs
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
SWORD Health: Reinventing the wheel for physiotherapy
AI-powered healthcare tech brings relief to overworked and understaffed physiotherapy providers
Benergy: A new app to track gut health with smart data
The Benergy app allows results to be shared with doctors to facilitate diagnosis and includes swap tests
Future Food Asia 2021 announces finalists for $100,000 prize
Ten startups from agrifood tech and cleantech sectors will pitch during the five-day conference, are also eligible for two more prizes from sponsors Cargill and Thai Wah
Future Food Asia 2021: Regenerative agriculture in Asia
The unique challenges facing regenerative agriculture in Asia require solutions different from those in the West, presenting opportunities for microfinancing and impact investment
NutraSign: Farm-to-fork traceability app for healthier lifestyles
NutraSign is an app that lets businesses and consumers identify and trace contaminated products within a food supply chain in seconds, using blockchain technology
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
Spanish tech companies launch multi-project Covid-19 portal to help citizens and authorities
Startups including Glovo, CARTO and Cabify join forces with the likes of Google, Apple and IBM in the #StopCorona initiative to help Spain fight the pandemic
Les Nouveaux Affineurs: Disrupting centuries-old French cheese culture
Backed by Michelin-star chefs and investors, Les Noveaux Affineurs is gearing up to be a global player in the billion-dollar vegan cheese market
Sorry, we couldn’t find any matches for “Health food”.
